Janux Therapeutics Inc. (JANX)
Market Closed
10 Sep, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
17. 68
-1.65
-8.536%
Pre Market
$
+0.57 +3.224% 18. 25
1.22B Market Cap
- P/E Ratio
- Div Yield
943,792 Volume
-1.35 Eps
$ 19.33
Previous Close 
Want to track JANX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Janux Therapeutics Inc. (JANX) Statistics
Valuation metrics
Market Cap 1.22B
Enterprise value 1.23B
Trailing P/E (ttm) -12.34
Forward P/E -
PEG ratio -1.73
Price/Sales (ttm) 38.72
Price/Book (mrq) 1.37
Enterprise Value/Revenue 38.51
Enterprise Value/EBITDA -12.14
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.04M
Average volume (90 days) 803.28K
Price summary
52-Week low 12.12
52-Week high 35.34
Beta -
50-Day moving average 17.34
200-Day moving average 14.71
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -3.22%
Operating margin -4.5%
Operational effectiveness
Return on assets -0.1%
Return on equity -0.11%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.51
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.63
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 15.43
Total debt (mrq) -
Total Debt/Equity (mrq) 0.02
Current ratio (mrq) 16.35%
Book value per share (mrq) 14.74
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
